GlassScriptPhysician profile
Irene P Malone
NPI 1578395984
$3,187.14
in general payments reported to CMS, 2019-2025
16 companies · $2,201 in 2025
The $2,201 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $986 · 2025: $2,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,187.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $901.06 | 2024-2025 | Fintepla, Briviact, Nayzilam |
| Neurelis, INC. | $488.54 | 2024-2025 | Valtoco |
| Corium, LLC | $400.59 | 2024-2025 | Azstarys |
| Jazz Pharmaceuticals INC. | $313.18 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $288.74 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $196.01 | 2024-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $140.28 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $95.69 | 2024-2025 | |
| Livanova USA, INC. | $72.66 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Aucta Pharmaceuticals, INC. | $72.28 | 2024-2025 | Motpoly Xr |
| Otter Pharmaceuticals, LLC | $58.37 | 2025 | Sympazan |
| Acadia Pharmaceuticals INC | $53.62 | 2025 | Daybue |
| Tris Pharma INC | $45.28 | 2025 | Dyanavel Xr |
| Ns Pharma, INC. | $27.48 | 2025 | Viltepso |
| Sumitomo Pharma America, INC. | $17.89 | 2024 | Aptiom |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $15.47 | 2025 | Xelstrym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.